... Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy — JAMA
Viral Suppression and HIV Transmission in Serodiscordant Male Couples: An International, Prospective, Observational, Cohort Study — The Lancet HIV
Swapping Daily Pills for Monthly Shots ...
Cómo funcionan los medicamentos inyectables para tratar y prevenir el VIH
... Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy — JAMA
Viral Suppression and HIV Transmission in Serodiscordant Male Couples: An International, Prospective, Observational, Cohort Study — The Lancet HIV
Swapping Daily Pills for Monthly Shots ...
... Referencias
Switch to Single-Tablet Bictegravir-Lenacapavir From a Complex HIV Regimen (Artistry-1): A Randomised, Open-Label, Phase 3 Clinical Trial — The Lancet
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy — Gilead
...
... Aidsmap
VIH: PrEP y PEP — MedlinePlus
Emtricitabine and Tenofovir — MedlinePlus
Profilaxis preexposición (PrEP) — HIVInfo.NIH.gov
Profilaxis posterior a la exposición — HIV.gov
How HIV Spreads — Centers for Disease Control and Prevention
Voluntary Medical Male Circumcisions for HIV Prevention — Morbidity and Mortality Weekly Report ...
VIH: causa, prevención y factores de riesgo
... Aidsmap
VIH: PrEP y PEP — MedlinePlus
Emtricitabine and Tenofovir — MedlinePlus
Profilaxis preexposición (PrEP) — HIVInfo.NIH.gov
Profilaxis posterior a la exposición — HIV.gov
How HIV Spreads — Centers for Disease Control and Prevention
Voluntary Medical Male Circumcisions for HIV Prevention — Morbidity and Mortality Weekly Report ...
... and Women — Wolters Kluwer UpToDate
...
... Centers for Disease Control and Prevention
La OMS recomienda el lenacapavir inyectable para la prevención del VIH — Organización Mundial de la Salud
...
... — Centers for Disease Control and Prevention
...
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
VIH-1 frente a VIH-2: ¿Cuáles son las diferencias y puede tener ambas?
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
... Department of Veterans Affairs
Stigma and HIV — Centers for Disease Control and Prevention
Supporting Retention in HIV Care Through a Holistic, Patient-Centred Approach: A Qualitative Evaluation — BMC Psychology
HIV Treatment as Prevention — Centers for Disease Control and Prevention ...
... — PrEP Daily
Sharing Your Status — Be in the Know
Disclosure of HIV-Positive Status: Towards the Development of Guidelines, Strategies and Interventions — Rapid Response Service
...
únete
